0000898432-23-000030.txt : 20230123 0000898432-23-000030.hdr.sgml : 20230123 20230123165934 ACCESSION NUMBER: 0000898432-23-000030 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230123 DATE AS OF CHANGE: 20230123 EFFECTIVENESS DATE: 20230123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Morphoceuticals, Inc. CENTRAL INDEX KEY: 0001962989 IRS NUMBER: 844555716 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-471540 FILM NUMBER: 23545063 BUSINESS ADDRESS: STREET 1: 47 GINGERBREAD HILL CITY: MARBLEHEAD STATE: MA ZIP: 01945 BUSINESS PHONE: 858-603-2514 MAIL ADDRESS: STREET 1: 47 GINGERBREAD HILL CITY: MARBLEHEAD STATE: MA ZIP: 01945 D 1 primary_doc.xml X0708 D LIVE 0001962989 Morphoceuticals, Inc. 47 GINGERBREAD HILL MARBLEHEAD MA MASSACHUSETTS 01945 858-603-2514 DELAWARE None None Corporation true 2020 Michael R. Hufford 1710 Murray Avenue Suite 200 Pittsburgh PA PENNSYLVANIA 15217 Executive Officer Director Alexander Pickett 47 Gingerbread Hill Marblehead MA MASSACHUSETTS 01945 Director Rosemarie Hunziker 613 Langston Lane Falls Church VA VIRGINIA 22046 Director Amy Kruse 702 Coybay Drive Annapolis MD MARYLAND 21401 Director David Gill 1st Floor Viking House St. Pauls Square Ramsey Y8 ISLE OF MAN IM8 1GB Executive Officer Michael Levin 47 Gingerbread Hill Marblehead MA MASSACHUSETTS 01945 Promoter David Kaplan 47 Gingerbread Hill Marblehead MA MASSACHUSETTS 01945 Promoter Biotechnology Decline to Disclose 06b false 2023-01-13 false true false 0 9820000 9820000 0 Includes the conversion of a convertible loan into equity. false 3 0 0 612000 true false Morphoceuticals, Inc. /s/ Michael R. Hufford Michael R. Hufford Interim Chief Executive Officer 2023-01-23